Publications Library

Transcription factor switching drives subtype-specific pancreatic cancer

Engineered cyclic peptide targeting ITGA5 disrupts tumor-stroma interaction to overcome desmoplasia and resistance in pancreatic ductal adenocarcinoma

SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer

SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence.

An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer

L-DOS47 Elevates Pancreatic Cancer Tumor pH and Enhances Response to Immunotherapy

A Preliminary Investigation of Radiation-Sensitive Ultrasound Contrast Agents for Photon Dosimetry

Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance

Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer

Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming